the best of professionals
Co-founder, Chief Scientific Officer
Dr. Morris-Irvin received his PhD in Pharmacology and Developmental Neuroscience with an emphasis on neural stem cell fate and differentiation. His research focused on neural development and Notch Signaling in mammalian neural stem cells. He also worked as an NIH/NINDS Post-Doctoral Fellow in Dr. Anders Bjorklund laboratory in Lund, Sweden. There, his focus was on research projects that investigated the potential role of cell replacement therapy for patients with Parkinson’s disease. They developed several protocols for the efficient generation of dopaminergic neurons from forebrain and ventral midbrain stem and progenitor cells. Dr. Morris-Irvin also worked as a Research Scientist, Assistant Professor, and Faculty member at Cedars-Sinai Medical Center, Department of Neurosurgery. He led research investigations in the role of adaptive immunity in Parkinson’s disease. He also developed two patents in the area of immunotherapy for brain tumor patients, specifically Glioblastoma Multiforme (GBM). He research team focused on molecular mechanisms that impart therapeutic resistance in cancer cells, including cancer stem cells. They utilized these data to develop novel immunotherapies for brain tumor patients.
Dr. Norris received his PhD from UCLA School of Medicine, Department of Molecular & Medical Pharmacology. His research focused on synthesizing molecular inhibitors against cancer cells. He also trained in the Surgical Oncology Department at UCLA focusing his research on novel drug discovery for breast cancer patients.
LEGAL AND FINANCIALPeter Weinstein, JD, Phd
Dr. Weinstein counsels in all aspects of Intellectual property, transaction & corporate law. He received his Juris Doctorate Degree at Boston College Law School. Dr. Weinstein is a registered patent attorney & is licensed to practice law in California & is admitted to the U.S. District Court for the Central & Southern Districts of California. Previously, Dr. Weinstein worked for many years as Senior Patent Counsel at Baxter Healthcare Corporation where he was responsible for managing legal & intellectual property matters for Baxter’s major hemophilia products like Advate® & major research & development programs in hemophilia. This work entailed working with multidisciplinary teams in the United States, Europe & Asia. Prior to Baxter, Dr. Weinstein worked in the San Diego Offices of the law firms of Brobeck, Phleger & Harrison and Fish & Richardson. Here, his practice focused on the management & prosecution of patent portfolios for biotech & high tech companies and patent & general civil litigation. During law school, he worked full-time as a patent agent in the Boston Office of Goodwin Procter. Dr. Weinstein also worked as an Examiner at the United States Patent & Trademark Office followed by a stint as a Senior Scientist at a biotech company where he was responsible for the Animal Health Group developing vaccines & other therapeutics for the treatment of infectious disease in large animals. Dr. Weinstein received his Ph.D. in Biology with an emphasis in Immunology from the University of Pennsylvania. Following receipt of his Ph.D., Dr. Weinstein worked as a Research Fellow, first at the National Institutes of Health in Bethesda, Maryland & then at the United States Army Medical Research Institute of Infectious Disease in Frederick, Maryland where he investigated the molecular development of antibody diversity & developed vaccines.
Steven Temple, L.R.A., L.I.A., L.S.A., E.A., M.S.
Chief Financial Officer
Steve Temple provides financial management services. He has more than 25 years of business management, accounting & tax experience. His firm manages it clients’ overall accounting, financial reporting, financial services & tax planning while simultaneously minimizing financial pitfalls. Steven Temple has a BS in Accounting from Arkansas Tech University & a Master’s Degree with emphasis in Entertainment & International Taxation from Golden Gate University. He holds licenses in real estate, insurance, securities (6&63) and his designation of Enroll Agent grants. He is currently a Los Angeles County Small Business Commissioner where he is involved in influencing policy changes for the betterment of local small businesses.